Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 430 shares of the company’s stock in a transaction dated Wednesday, January 28th. The stock was sold at an average price of $31.67, for a total transaction of $13,618.10. Following the completion of the sale, the chief operating officer owned 31,861 shares in the company, valued at approximately $1,009,037.87. This trade represents a 1.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Trupanion Stock Performance
Shares of TRUP opened at $32.17 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31. The stock has a market cap of $1.39 billion, a P/E ratio of 89.36 and a beta of 1.58. The business’s 50 day moving average price is $35.64 and its 200-day moving average price is $41.48. Trupanion, Inc. has a 52 week low of $30.85 and a 52 week high of $57.88.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings data on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The company had revenue of $366.92 million for the quarter, compared to the consensus estimate of $361.58 million. During the same period last year, the business earned $0.03 EPS. The firm’s quarterly revenue was up 12.0% on a year-over-year basis. Equities research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several analysts recently commented on the stock. Wall Street Zen downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. Cantor Fitzgerald reduced their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research report on Wednesday, January 14th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 29th. Finally, Piper Sandler cut their target price on Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, December 19th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and an average target price of $50.00.
Get Our Latest Stock Analysis on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Buy this Gold Stock Before May 2026
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
